Efficacy of dupilumab in patients with aspirin-exacerbated respiratory disease and previous inadequate response to anti-IL-5 or anti-IL-5Rα in a real-world setting

Authors :: Jillian C. Bensko
Tanya M. Laidlaw
Anisha Mittal
Kathleen M. Buchheit
Deborah Gakpo
Nicole Bavaro
Source :: J Allergy Clin Immunol Pract
Publication Year :: 2021
Publisher :: Elsevier BV, 2021.

Subjects :: Aspirin
business.industry
Antibodies, Monoclonal, Humanized
Dupilumab
Article
Anti il 5
Immunology
Humans
Immunology and Allergy
Medicine
Aspirin exacerbated respiratory disease
In patient
Sinusitis
business

Tools